Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort

Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. This study aimed to assess the prevalence of hepatitis B virus (HBV), hepatitis delta virus (HDV), hepatitis C virus (...

Full description

Saved in:
Bibliographic Details
Main Authors: Antoanela Curici, Olivia Mioara Ilie, Dana Elena Mindru
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/13/1/118
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587844681465856
author Antoanela Curici
Olivia Mioara Ilie
Dana Elena Mindru
author_facet Antoanela Curici
Olivia Mioara Ilie
Dana Elena Mindru
author_sort Antoanela Curici
collection DOAJ
description Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. This study aimed to assess the prevalence of hepatitis B virus (HBV), hepatitis delta virus (HDV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) co-infections in a cohort of 426,528 patients tested for HBsAg in Romania between 2018 and 2023. Of the 17,082 HBsAg-positive individuals (4.0% prevalence), the highest HBV positivity rates were observed in the 30–39 and over 60 age groups. Chronic HBV infection was identified in 13.2% of the cohort, with 3.6% testing positive for HBeAg, indicating active viral replication. Co-infection rates were 11.3% for HDV, 1.4% for HCV, and 0.45% for HIV. The incidence of HDV co-infection increased significantly from 2018 to 2023, particularly in older populations. HCV co-infection was more prevalent in individuals aged 50–59 and over 60, with a declining trend from 2020 onward. The study also revealed a weak correlation between liver enzyme levels (ALT and AST) and HBV viral load, suggesting that liver function tests may not fully reflect the severity of HBV infection. HIV co-infection was notably rare compared to other regions, likely due to regional healthcare interventions. The findings from our study highlight the need for targeted interventions, particularly for high-risk groups such as older adults and middle-aged individuals, to reduce the burden of chronic HBV and its complications.
format Article
id doaj-art-47bca5683b6a46c3bf1814a61eca7950
institution Kabale University
issn 2076-2607
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj-art-47bca5683b6a46c3bf1814a61eca79502025-01-24T13:42:43ZengMDPI AGMicroorganisms2076-26072025-01-0113111810.3390/microorganisms13010118Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian CohortAntoanela Curici0Olivia Mioara Ilie1Dana Elena Mindru2Department of Cellular and Molecular Biology and Histology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, RomaniaSynevo Romania, 021408 Bucharest, RomaniaDepartment of Pediatrics, Faculty of Medicine, “Grigore T. Popa” University of Medicine and Pharmacy, 700115 Iasi, RomaniaHepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. This study aimed to assess the prevalence of hepatitis B virus (HBV), hepatitis delta virus (HDV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) co-infections in a cohort of 426,528 patients tested for HBsAg in Romania between 2018 and 2023. Of the 17,082 HBsAg-positive individuals (4.0% prevalence), the highest HBV positivity rates were observed in the 30–39 and over 60 age groups. Chronic HBV infection was identified in 13.2% of the cohort, with 3.6% testing positive for HBeAg, indicating active viral replication. Co-infection rates were 11.3% for HDV, 1.4% for HCV, and 0.45% for HIV. The incidence of HDV co-infection increased significantly from 2018 to 2023, particularly in older populations. HCV co-infection was more prevalent in individuals aged 50–59 and over 60, with a declining trend from 2020 onward. The study also revealed a weak correlation between liver enzyme levels (ALT and AST) and HBV viral load, suggesting that liver function tests may not fully reflect the severity of HBV infection. HIV co-infection was notably rare compared to other regions, likely due to regional healthcare interventions. The findings from our study highlight the need for targeted interventions, particularly for high-risk groups such as older adults and middle-aged individuals, to reduce the burden of chronic HBV and its complications.https://www.mdpi.com/2076-2607/13/1/118hepatitis Bhepatitis deltaprevalenceliver enzymeHCVHIV
spellingShingle Antoanela Curici
Olivia Mioara Ilie
Dana Elena Mindru
Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
Microorganisms
hepatitis B
hepatitis delta
prevalence
liver enzyme
HCV
HIV
title Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
title_full Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
title_fullStr Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
title_full_unstemmed Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
title_short Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
title_sort prevalence of hdv hcv and hiv infection in the population of patients infected with hbv in a romanian cohort
topic hepatitis B
hepatitis delta
prevalence
liver enzyme
HCV
HIV
url https://www.mdpi.com/2076-2607/13/1/118
work_keys_str_mv AT antoanelacurici prevalenceofhdvhcvandhivinfectioninthepopulationofpatientsinfectedwithhbvinaromaniancohort
AT oliviamioarailie prevalenceofhdvhcvandhivinfectioninthepopulationofpatientsinfectedwithhbvinaromaniancohort
AT danaelenamindru prevalenceofhdvhcvandhivinfectioninthepopulationofpatientsinfectedwithhbvinaromaniancohort